bacterioruberin: C(50) carotenoid pigment; structure
bacterioruberin : A C50 carotenoid that is a red-coloured pigment found in several Halobacterium and Haloarcula species.
ID Source | ID |
---|---|
PubMed CID | 6441558 |
CHEBI ID | 49388 |
MeSH ID | M0043802 |
Synonym |
---|
bacterioruberin |
(5s,6e,8e,10e,12e,14e,16e,18e,20e,22e,24e,26e,28e,30e,32s)-5,32-bis(2-hydroxypropan-2-yl)-2,8,12,16,21,25,29,35-octamethylhexatriaconta-6,8,10,12,14,16,18,20,22,24,26,28,30-tridecaene-2,35-diol |
32719-43-0 |
psi,psi-carotene, 3,3',4,4'-tetradehydro-1,1',2,2'-tetrahydro-1,1'-dihydroxy-2,2'-bis(3-hydroxy-3-methylbutyl)-, (2s,2's)- |
(2s,2's)-2,2'-bis(3-hydroxy-3-methylbutyl)-3,4,3',4'-tetradehydro-1,2,1',2'-tetrahydro-y,y-carotene-1,1'-diol |
(2s,2's)-2,2'-bis(3-hydroxy-3-methylbutyl)-3,4,3',4'-tetradehydro-1,2,1',2'-tetrahydro-gamma,gamma-carotene-1,1'-diol |
(5s,,6e,8e,10e,12e,14e,16e,18e,20e,22e,24e,26e,28e,30e,32s)-5,32-bis(2-hydroxypropan-2-yl)-2,8,12,16,21,25,29,35-octamethylhexatriaconta-6,8,10,12,14,16,18,20,22,24,26,28,30-tridecaene-2,35-diol |
CHEBI:49388 |
Q15478206 |
DTXSID201316959 |
Role | Description |
---|---|
biological pigment | An endogenous molecular entity that results in a colour of an organism as the consequence of the selective absorption of light. |
bacterial metabolite | Any prokaryotic metabolite produced during a metabolic reaction in bacteria. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
C50 carotenoid | Any polyterpenoid derived from a carotenoid by addition of two five-carbon units to the C40 skeleton. |
tertiary alcohol | A tertiary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has three other carbon atoms attached to it. |
tetrol | A polyol that contains 4 hydroxy groups. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Pathway | Proteins | Compounds |
---|---|---|
bacterioruberin biosynthesis | 2 | 10 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (6.25) | 18.7374 |
1990's | 2 (6.25) | 18.2507 |
2000's | 4 (12.50) | 29.6817 |
2010's | 15 (46.88) | 24.3611 |
2020's | 9 (28.13) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (31.35) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (3.13%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 31 (96.88%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |